Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,046 followers.

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cel… https://t.co/HrWL5bBvNt https://t.co/L4ROLQzXbG

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.